These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 18358096)
1. LY294002 induces p53-dependent apoptosis of SGC7901 gastric cancer cells. Xing CG; Zhu BS; Liu HH; Lin F; Yao HH; Liang ZQ; Qin ZH Acta Pharmacol Sin; 2008 Apr; 29(4):489-98. PubMed ID: 18358096 [TBL] [Abstract][Full Text] [Related]
2. Class I phosphatidylinositol 3-kinase inhibitor LY294002 activates autophagy and induces apoptosis through p53 pathway in gastric cancer cell line SGC7901. Xing C; Zhu B; Liu H; Yao H; Zhang L Acta Biochim Biophys Sin (Shanghai); 2008 Mar; 40(3):194-201. PubMed ID: 18330473 [TBL] [Abstract][Full Text] [Related]
3. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR. Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116 [TBL] [Abstract][Full Text] [Related]
4. [Effects of combined therapy of LY294002 and SN50 on nude mice model with gastric cancer]. Sun JL; Zhu BS; Gong W; Zhang P; Yu LY; Zhao K; Xing CG Zhonghua Wei Chang Wai Ke Za Zhi; 2011 May; 14(5):364-7. PubMed ID: 21614693 [TBL] [Abstract][Full Text] [Related]
5. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells. Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465 [TBL] [Abstract][Full Text] [Related]
6. LY294002, an inhibitor of PI-3K, enhances heat sensitivity independently of p53 status in human lung cancer cells. Ohnishi K; Yasumoto J; Takahashi A; Ohnishi T Int J Oncol; 2006 Jul; 29(1):249-53. PubMed ID: 16773206 [TBL] [Abstract][Full Text] [Related]
7. GSK-3beta reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis. Beurel E; Kornprobst M; Blivet-Van Eggelpoël MJ; Cadoret A; Capeau J; Desbois-Mouthon C Int J Oncol; 2005 Jul; 27(1):215-22. PubMed ID: 15942663 [TBL] [Abstract][Full Text] [Related]
8. The phosphoinositide 3-kinase inhibitor LY294002, decreases aminoacyl-tRNA synthetases, chaperones and glycolytic enzymes in human HT-29 colorectal cancer cells. Mallawaaratchy DM; Mactier S; Kaufman KL; Blomfield K; Christopherson RI J Proteomics; 2012 Feb; 75(5):1590-9. PubMed ID: 22172953 [TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Lee CM; Fuhrman CB; Planelles V; Peltier MR; Gaffney DK; Soisson AP; Dodson MK; Tolley HD; Green CL; Zempolich KA Clin Cancer Res; 2006 Jan; 12(1):250-6. PubMed ID: 16397049 [TBL] [Abstract][Full Text] [Related]
10. Effects of small interfering RNA inhibit Class I phosphoinositide 3-kinase on human gastric cancer cells. Zhu BS; Yu LY; Zhao K; Wu YY; Cheng XL; Wu Y; Zhong FY; Gong W; Chen Q; Xing CG World J Gastroenterol; 2013 Mar; 19(11):1760-9. PubMed ID: 23555164 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766 [TBL] [Abstract][Full Text] [Related]
12. The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis. Bar J; Lukaschuk N; Zalcenstein A; Wilder S; Seger R; Oren M Cell Death Differ; 2005 Dec; 12(12):1578-87. PubMed ID: 15933740 [TBL] [Abstract][Full Text] [Related]
13. Enhanced anti-cancer effect of a phosphatidylinositol-3 kinase inhibitor and doxorubicin on human breast epithelial cell lines with different p53 and oestrogen receptor status. Wang YA; Johnson SK; Brown BL; McCarragher LM; Al-Sakkaf K; Royds JA; Dobson PR Int J Cancer; 2008 Oct; 123(7):1536-44. PubMed ID: 18634052 [TBL] [Abstract][Full Text] [Related]
14. [Impact of PI3K /Akt /mdm2 signaling pathway on the sensitivity of gastric cancer cell line SGC7901 to doxorubicin]. Ai YW; Yu HG; Yu JP; Yang Y; Li H; Hu XW; Luo HS Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):494-7. PubMed ID: 19062713 [TBL] [Abstract][Full Text] [Related]
15. Osteopontin prevents curcumin-induced apoptosis and promotes survival through Akt activation via alpha v beta 3 integrins in human gastric cancer cells. Song G; Ming Y; Mao Y; Bao S; Ouyang G Exp Biol Med (Maywood); 2008 Dec; 233(12):1537-45. PubMed ID: 18849546 [TBL] [Abstract][Full Text] [Related]
16. [The relationship of mTOR signaling pathway and histone acetylation in human gastric cancer cell lines]. Sun DF; Fang JY; Zhang YJ; Tian XQ; Zhu HY; Li EL; Gu WQ; Shen GF Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):387-91. PubMed ID: 17680526 [TBL] [Abstract][Full Text] [Related]
17. MAPK and PI3K inhibition reduces proliferation of Barrett's adenocarcinoma in vitro. Vona-Davis L; Frankenberry K; Cunningham C; Riggs DR; Jackson BJ; Szwerc MF; McFadden DW J Surg Res; 2005 Jul; 127(1):53-8. PubMed ID: 15964304 [TBL] [Abstract][Full Text] [Related]
18. [Reversal effect of PI-3K/Akt pathway inhibitor LY294002 on multidrug resistance of ovarian cancer cell line A2780/Taxol]. Shi XY; Cai XJ; Lei JX; Cao FJ; Pan DF; Chen P Ai Zheng; 2008 Apr; 27(4):343-7. PubMed ID: 18423117 [TBL] [Abstract][Full Text] [Related]
19. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells. Semba S; Itoh N; Ito M; Harada M; Yamakawa M Clin Cancer Res; 2002 Jun; 8(6):1957-63. PubMed ID: 12060641 [TBL] [Abstract][Full Text] [Related]
20. [Expression of phosphatidylinositol-3 kinase in epithelial ovarian carcinoma]. Zhang PN; Sun H Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):196-200. PubMed ID: 17537308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]